Department of Gynecology and Obstetrics, Otto-von-Guericke University, Magdeburg, Germany.
Department of Gynecology and Obstetrics, Otto-von-Guericke University, Magdeburg, Germany.
Gynecol Oncol. 2022 Jul;166(1):57-60. doi: 10.1016/j.ygyno.2022.05.014. Epub 2022 May 23.
The aim of this study was to investigate the impact of pre-operative conization on disease-free survival (DFS) in early-stage cervical cancer.
In this population-based cohort study we analysed from clinical cancer registries to determine DFS of women with International Federation of Gynecology and Obstetrics (FIGO) stage IA1-IB1 cervical cancer with respect to conization preceding radical hysterectomy performed between January 2010 and December 2015.
Out of 993 datasets available for the analysis, 235 patients met the inclusion criteria of the current study. The median follow-up was 5.4 years. During the study period, 28 (11.9%) recurrences were observed. All of these occurred in patients with FIGO stage IB1. For further evaluation, patients with FIGO IB1 tumors <2 cm were further analysed and divided into two groups, based on pre-operative conization. Pre-operative conization was associated with a reduced rate of recurrence (p = 0.007), with only three (5.2%) recurrences in this group (CO) compared to 25 recurrences (21.0%) in the group without conization (NCO) preceding radical hysterectomy. DFS was estimated at 79.0% and 94.8% in NCO and CO, respectively (p = 0.008). After adjustment for other prognostic covariates, conization remained a favourable prognostic factor for DFS (HR 0.27; 95% CI 0.08-0.93, p = 0.037). Lymph node involvement was the only unfavourable factor (HR 4.38; 95% CI 1.36-14.14, p = 0.014) in the multivariable analysis.
Pre-operative conization is associated with improved DFS in early-stage cervical cancer independently of the surgical approach.
本研究旨在探讨术前锥切术对早期宫颈癌无病生存(DFS)的影响。
在这项基于人群的队列研究中,我们分析了临床癌症登记处的数据,以确定在 2010 年 1 月至 2015 年 12 月期间接受根治性子宫切除术的国际妇产科联合会(FIGO)分期为 IA1-IB1 的宫颈癌患者,锥切术对DFS的影响。
在可用于分析的 993 个数据集,有 235 名患者符合本研究的纳入标准。中位随访时间为 5.4 年。在研究期间,观察到 28 例(11.9%)复发。所有这些都发生在 FIGO 分期为 IB1 的患者中。为了进一步评估,将 FIGO IB1 肿瘤<2cm 的患者进一步分析,并根据术前锥切术分为两组。与未行锥切术的患者相比,行术前锥切术的患者复发率降低(p=0.007),在这组患者中仅有 3 例(5.2%)复发(CO 组),而在未行锥切术的患者中,25 例(21.0%)患者复发(NCO 组)。NCO 和 CO 组的 DFS 分别估计为 79.0%和 94.8%(p=0.008)。在调整其他预后协变量后,锥切术仍然是 DFS 的有利预后因素(HR 0.27;95%CI 0.08-0.93,p=0.037)。淋巴结受累是多变量分析中唯一的不利因素(HR 4.38;95%CI 1.36-14.14,p=0.014)。
术前锥切术与早期宫颈癌的 DFS 改善相关,独立于手术方式。